Table 4.
Distribution of Maternal STI Status and HIV MTCT
| Total n (%) |
Any STI (CT, NG, or CT & NG Co-Infected) | CT & NG Co-Infected n (%) |
CT Only n (%) |
NG Only n (%) |
No CT & NG Infection n (%) |
p-value | |
|---|---|---|---|---|---|---|---|
| Maternal STI Infection | 1373 (100.0) | 277 (20.2) | 35 (2.6) | 214 (15.6) | 28 (2.0) | 1096 (79.8) | ----- |
| Total Infant HIV Infection | 117 (8.5) | 28 (10.1) | 5 (14.3) | 23 (10.7) | 0 (0) | 89 (8.1) | 0.04 |
| HIV-Infected In Utero | 75 (5.5) | 19 (6.9) | 3 (8.6) | 16 (7.5) | 0 (0.0) | 56 (5.1) | 0.02 |
| HIV-Infected Intrapartum | 42 (3.1) | 9 (3.2) | 2 (5.7) | 7 (3.3) | 0 (0.0) | 33 (3.0) | < 0.05 |
| HIV Uninfected | 1182 (86.1) | 235 (84.5) | 24 (68.6) | 183 (85.5) | 28 (100.0) | 947 (86.4) | ---- |
| HIV Status Unknown | 74 (5.4) | 14 (5.1) | 6 (17.1) | 8 (3.7) | 0 (0.0) | 60 (5.5) | ----- |
This table evaluates the distribution of HIV MTCT by maternal STI group. In the frequency distribution above, p-values were from the exact test with Monte Carlo simulations. A p-value of 0.05 or less indicates that at least one significant finding among four STI infection groups was detected among all infants. Significant differences were noted among STI groups for rates of overall HIV MTCT as well as for in utero and intrapartum HIV MTCT.